Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hyperprolactinemia × Cabergoline × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prolactinoma 1 Pituitary Neoplasms 1 Pituitary ACTH Hypersecretion 1 Hyperprolactinemia 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07463235 2026-03-13

SPARAGMOS

University of Sao Paulo General Hospital

Phase 3 Recruiting

Hyperprolactinemia, Prolactinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡